Frontiers in Immunology, 2024 · DOI: 10.3389/fimmu.2024.1432841 · Published: August 29, 2024
Traumatic spinal cord injury (tSCI) leads to a local microenvironmental imbalance in the spinal cord, including accumulation of cytokines and chemokines, reduced angiogenesis, dysregulation of cellular energy metabolism, and dysfunction of immune cells at the site of injury, which severely impedes neurological recovery from spinal cord injury (SCI). Spatial multi-omics technology combines data from immunohistochemistry and multiparametric analysis to reveal the changes in the microenvironment at different times of secondary injury after SCI. The review systematically examines the progress of spatial multi-omics techniques in studying the microenvironment after SCI, covering changes in the immune microenvironment and potential future therapeutic strategies.
Spatial multi-omics enables precision medicine and personalized treatment strategies for spinal cord injury.
Spatial transcriptomics has the potential to discover new cellular biomarkers, such as Glmp and Nfe2l2, which are DAM-specific transcription factors in SCI.
Spatial multi-omics may reveal the mechanism of promoting SCI repair based on biomaterials such as scaffolds and hydrogels, aiding in the design of better therapeutic interventions.